Company Filing History:
13 out of 2,198 
6 out of 207 Years Active: 1985-2002
Title: Innovations and Contributions of Thomas Wen-Fu Ku
Introduction: Thomas Wen-Fu Ku, based in Dresher, Pennsylvania, is a notable inventor with a remarkable portfolio of 19 patents. His work primarily focuses on biochemical advancements, which have significant implications for treating various disease states.
Latest Patents: Among his recent innovations is a patent for "Bicyclic Fibrinogen Antagonists - Compounds and Methods." This invention pertains to substituted heteroanilide compounds that function as modulators, agonists, or antagonists of the CCR5 receptor. It plays a crucial role in the treatment and prevention of diseases mediated by CCR5, highlighting his contributions to medical science and pharmacology.
Career Highlights: Thomas has made significant strides during his career, notably working with renowned organizations such as the SmithKline Beecham Corporation and the SmithKline Beckman Corporation. His expertise in research and development has helped pave the way for innovative therapies and medicinal solutions.
Collaborations: Throughout his career, Thomas has collaborated with esteemed colleagues, including William Edward Bondinell and John G. Gleason. These partnerships reflect his commitment to advancing scientific knowledge and enhancing healthcare through innovative solutions.
Conclusion: Thomas Wen-Fu Ku continues to be a driving force in the field of biomedical innovation. His substantial contributions, evident through his patents and collaborative efforts, significantly impact the understanding and treatment of various diseases, illustrating the power of creativity and invention in healthcare.